Drug resistance mutations: yes but where?

Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach.

Retrovirology·2009

HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy.

AIDS (London, England)·2008

Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.

AIDS (London, England)·2007

Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types.

Archives of internal medicine·2007

New complete genome sequences of human rhinoviruses shed light on their phylogeny and genomic features.

BMC genomics·2007

Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2007

Longitudinal trends in copy-years viremia associated with mpox acquisition but not mpox severity in people with HIV.

AIDS (London, England)·2026

Sex differences in long-acting cabotegravir trough concentrations in the SEARCH study in Kenya and Uganda.

AIDS (London, England)·2026

Changes in neurodevelopmental outcomes from 24 to 36 months among children HIV-exposed uninfected (CHEU) and HIV-unexposed (CHU).

AIDS (London, England)·2026

Reframing analytical treatment interruption through participants' and decliners' eyes: insights from an HIV remission trial.

AIDS (London, England)·2026

Ninety-six-week observational outcomes of long-acting injectable HIV therapy in people with adherence challenges, including people who use drugs.

AIDS (London, England)·2026

Evolving drivers of preexposure prophylaxis discontinuation among US MSM, 2018-2024.

AIDS (London, England)·2026

Comparative Study of Medication Adherence and Glycemic Control in Type 2 Diabetes Mellitus Patients on Oral Hypoglycemics versus Insulin Therapy.

Journal of pharmacy & bioallied sciences·2026

Drug Utilization Pattern and Maternal Outcomes of Obstetric Medications in Antenatal and Postnatal Women at a Tertiary Care Hospital.

Journal of pharmacy & bioallied sciences·2026

Efficacy and Safety of Pioglitazone in Improving Cognitive Function among Patients with Impaired Cognition as an Add-On Therapy: A Study Protocol.

Biomedicine hub·2026

Assessment of Drug Therapy Awareness, Medication Adherence, and Predictors of Knowledge, Attitude, and Practice on Diabetic Complications in Type 2 Diabetes Mellitus: A Cross-Sectional Study.

Journal of pharmacy & bioallied sciences·2026

Evaluation of Pharmacovigilance Reporting Patterns and Adverse Drug Reactions in a Tertiary Care Teaching Hospital.

Journal of pharmacy & bioallied sciences·2026

Pharmacodynamic modeling of colistin and imipenem against in vitro Pseudomonas aeruginosa biofilms.

Biofilm·2026

Related Experiment Videos

Drug resistance mutations: yes but where?

Related Concept Videos

Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach.

HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy.

Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.

Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types.

New complete genome sequences of human rhinoviruses shed light on their phylogeny and genomic features.

Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.

Longitudinal trends in copy-years viremia associated with mpox acquisition but not mpox severity in people with HIV.

Sex differences in long-acting cabotegravir trough concentrations in the SEARCH study in Kenya and Uganda.

Changes in neurodevelopmental outcomes from 24 to 36 months among children HIV-exposed uninfected (CHEU) and HIV-unexposed (CHU).

Reframing analytical treatment interruption through participants' and decliners' eyes: insights from an HIV remission trial.

Ninety-six-week observational outcomes of long-acting injectable HIV therapy in people with adherence challenges, including people who use drugs.

Evolving drivers of preexposure prophylaxis discontinuation among US MSM, 2018-2024.

Comparative Study of Medication Adherence and Glycemic Control in Type 2 Diabetes Mellitus Patients on Oral Hypoglycemics versus Insulin Therapy.

Drug Utilization Pattern and Maternal Outcomes of Obstetric Medications in Antenatal and Postnatal Women at a Tertiary Care Hospital.

Efficacy and Safety of Pioglitazone in Improving Cognitive Function among Patients with Impaired Cognition as an Add-On Therapy: A Study Protocol.

Assessment of Drug Therapy Awareness, Medication Adherence, and Predictors of Knowledge, Attitude, and Practice on Diabetic Complications in Type 2 Diabetes Mellitus: A Cross-Sectional Study.

Evaluation of Pharmacovigilance Reporting Patterns and Adverse Drug Reactions in a Tertiary Care Teaching Hospital.

Pharmacodynamic modeling of colistin and imipenem against in vitro Pseudomonas aeruginosa biofilms.

Related Experiment Videos

Drug resistance mutations: yes but where?

Related Concept Videos

Related Articles